Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000215852 | SCV000278399 | likely benign | Hereditary cancer-predisposing syndrome | 2015-09-16 | criteria provided, single submitter | clinical testing | Synonymous alterations with insufficient evidence to classify as benign |
Labcorp Genetics |
RCV000468081 | SCV000554912 | likely benign | Neurofibromatosis, type 1 | 2024-11-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000468081 | SCV002561311 | likely benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001579778 | SCV001808483 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001579778 | SCV001928250 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727641 | SCV001971629 | benign | not specified | no assertion criteria provided | clinical testing |